Herbal Dispatch Inc. has completed its largest international export shipment of 500 kilograms of medical cannabis to Europe, marking a key milestone in its expanding global business. This shipment supports the company's strategy to build recurring supply relationships in regulated medical cannabis markets, where demand for premium Canadian products is rising. Europe remains a major growth region due to increasing patient adoption and regulatory support. Herbal Dispatch plans further shipments under existing permits, strengthening its international network across multiple countries and positioning itself for long-term growth in the global medical cannabis supply chain.
Acoramidis, a drug for transthyretin amyloid cardiomyopathy (ATTR-CM), was linked to an 18% lower risk of death, hospitalization, and disease progression compared to tafamidis in a large U.S. electronic health record study of 2,684 patients. The stud...
Stellantis revealed six concept cars from its iconic brands at an exclusive event before the Paris Motor Show, highlighting its FaSTLAne 2030 strategy focused on innovation, customer experience, and diverse mobility solutions. These concepts, includi...
Freenome announced improved clinical validation results for its updated SimpleScreen™ CRC blood test, showing an 18.2% sensitivity for advanced precancerous lesions (APLs), up from 13.7% in the original test. Sensitivity for high-grade dysplasia APLs...
Donaldson Company is rated Buy due to its strong recurring replacement demand and diversified filtration portfolio that supports margin recovery and growth. The company's installed base and aftermarket sales provide resilience, while acquisitions lik...
Latigo Biotherapeutics is currently trading below its IPO value despite showing strong potential with its drug onzotrigine, which has demonstrated better efficacy in acute pain compared to Vertex's Journavx. The company benefits from leveraging Verte...
